Mission Statement, Vision, & Core Values of 2seventy bio, Inc. (TSVT)

In the complex world of biopharmaceutical companies, understanding a company's core values, mission, and vision is crucial, especially when considering their impact on patients and stakeholders. Have you ever wondered what drives a company like 2seventy bio, particularly given their focus on innovative cancer treatments? How do these guiding principles translate into tangible actions and financial results, such as the $242 million in U.S. sales generated by Abecma in 2024?

Exploring 2seventy bio's mission, vision, and core values provides insight into their strategic direction, especially as they navigate significant changes, including a merger agreement with Bristol Myers Squibb at $5.00 per share, expected to close in the second quarter of 2025. What role do these foundational elements play in shaping their approach to cell therapy and their commitment to providing more time for patients?

2seventy bio, Inc. (TSVT) An Overview of

2seventy bio, Inc. (TSVT), is a biotechnology company focused on researching, developing, and commercializing gene and cell therapies for cancer and other critical diseases. The company emerged from bluebird bio, separating to focus on oncology while bluebird bio concentrates on severe genetic diseases. 2seventy bio's primary focus is on developing therapies for hematologic malignancies, solid tumors, and autoimmune diseases.

As of April 2025, 2seventy bio markets Abecma, a CAR-T cell therapy approved for the treatment of adult patients with relapsed or refractory multiple myeloma. Beyond Abecma, 2seventy bio is advancing a pipeline of novel cell therapies, including programs targeting hematologic malignancies and solid tumors. These therapies utilize innovative approaches such as next-generation CAR T-cell technology and gene editing to enhance efficacy and reduce toxicity.

Recent financial reports highlight 2seventy bio's performance. In 2024, 2seventy bio reported total revenues of $167.4 million, which primarily included net product revenues from Abecma. The company's revenue from Abecma in 2024 was $166.3 million. Research and development expenses totaled $171.1 million, and selling, general, and administrative expenses were $121.7 million. The company reported a net loss of $238.9 million for the year. As of December 31, 2024, 2seventy bio had cash, cash equivalents, and marketable securities of $174.9 million.

2seventy bio faces several challenges, including the high costs associated with developing and commercializing cell therapies, regulatory hurdles, and competition from other companies in the gene and cell therapy space. The company is actively working to manage its expenses and extend its cash runway through strategic partnerships and pipeline prioritization.

2seventy bio stands as one of the innovative companies in the biotechnology sector, particularly in the field of cell and gene therapy. Its commitment to developing novel therapies for cancer and other serious diseases underscores its potential impact on healthcare. To delve deeper into the factors driving 2seventy bio's achievements and strategic direction, explore: Exploring 2seventy bio, Inc. (TSVT) Investor Profile: Who’s Buying and Why?

2seventy bio, Inc. (TSVT) Mission Statement of

The mission statement of 2seventy bio, Inc. is 'to discover and develop transformative cell and gene therapies for cancer and other critical diseases.' This statement underscores the company's dedication to innovative medical solutions and improving patient outcomes through advanced therapeutic approaches.

The mission statement embodies three core components:

• Discovery and Development: 2seventy bio focuses on the initial research (discovery) and subsequent advancement (development) of new therapies. This involves identifying promising biological targets, creating therapeutic candidates, and rigorously testing them through preclinical and clinical trials.
• Transformative Cell and Gene Therapies: The company specializes in cell and gene therapies, which are cutting-edge treatments that modify a patient's cells or genes to fight disease. These therapies hold the potential to fundamentally change the course of diseases, offering long-lasting benefits or even cures.
• Cancer and Other Critical Diseases: 2seventy bio targets cancer and other critical diseases, indicating a focus on severe and life-threatening conditions. This focus helps prioritize research efforts and ensures that the company's resources are directed towards areas with the greatest unmet medical need.

2seventy bio's commitment to delivering high-quality products and services is reflected in its strategic approach to research and development. As of the fiscal year 2024, the company reported investing $173.9 million in research and development. These investments are crucial for advancing their pipeline of cell and gene therapies, demonstrating a strong emphasis on innovation and scientific excellence. 2seventy bio's dedication to quality extends beyond research and development, influencing every aspect of its operations, from manufacturing to patient care. By adhering to rigorous standards and continuously seeking improvements, the company aims to ensure that its therapies are safe, effective, and accessible to patients in need.

To gain further insights into 2seventy bio, Inc., explore this resource: 2seventy bio, Inc. (TSVT): History, Ownership, Mission, How It Works & Makes Money

2seventy bio, Inc. (TSVT) Vision Statement

To fully understand 2seventy bio, Inc.'s direction, it's crucial to examine its mission, vision, and core values. These elements work together to define the company's purpose, desired future, and guiding principles. For a broader understanding of 2seventy bio, Inc., you might find this link helpful: 2seventy bio, Inc. (TSVT): History, Ownership, Mission, How It Works & Makes Money.

As of April 2025, 2seventy bio, Inc. operates with a clear vision, mission and core values. While specific forward-looking statements are subject to change, understanding these foundational elements provides insight into the company's strategic direction.

2seventy bio, Inc. focuses on cell and gene therapy. The company is dedicated to discovering and developing treatments for cancer and other severe diseases. Their approach involves harnessing the power of cell therapy to create personalized treatments.

Mission Statement

While the vision statement looks to the future, the mission statement defines the company's current purpose and activities. The mission statement of 2seventy bio is:

“To become the leading cell and gene therapy company, translating the science into the clinic and, ultimately, into cures.”

• Leading Cell and Gene Therapy Company: 2seventy bio, Inc. aims to be at the forefront of the cell and gene therapy field.
• Translating Science: The company is committed to converting scientific discoveries into practical clinical applications.
• Cures: The ultimate goal is to develop curative therapies for patients.

Vision

The vision of 2seventy bio is to deliver innovative cell and gene therapies to patients in need.

To achieve this vision, 2seventy bio focuses on:

• Developing novel cell and gene therapies for cancer and other serious diseases.
• Advancing its research and development programs.
• Expanding its pipeline of product candidates.
• Collaborating with other companies and institutions.

Core Values

2seventy bio's core values are the fundamental beliefs that guide its actions and decisions. These values reflect the company's culture and commitment to its mission and vision.

2seventy bio's core values include:

• Patients First: Prioritizing the needs and well-being of patients.
• Innovation: Fostering a culture of creativity and continuous improvement.
• Integrity: Maintaining the highest ethical standards in all activities.
• Collaboration: Working together effectively to achieve common goals.
• Excellence: Striving for the highest quality in all aspects of the business.

2seventy bio, Inc. (TSVT) Core Values of

At 2seventy bio, Inc. (TSVT), a commitment to core values underpins every facet of the organization, guiding its strategic decisions, operational practices, and interactions with stakeholders. These values reflect 2seventy bio's dedication to innovation, patient care, and ethical conduct. You can gain more insights about the company’s performance here: Breaking Down 2seventy bio, Inc. (TSVT) Financial Health: Key Insights for Investors.

Patients and their families first

2seventy bio places patients and their families at the forefront of its mission. This commitment is evident in the company's focus on developing innovative cell and gene therapies for severe diseases. By prioritizing the needs of patients, 2seventy bio aims to deliver transformative treatments that improve outcomes and enhance the quality of life.

Examples of how 2seventy bio demonstrates this value include:

• Development of novel therapies: Focusing on areas with significant unmet medical needs.
• Patient advocacy: Engaging with patient communities to understand their experiences and needs.
• Clinical trial design: Incorporating patient perspectives to ensure trials are patient-centric.

Innovation

Innovation is a driving force at 2seventy bio. The company fosters a culture of creativity and scientific rigor to advance the field of cell and gene therapy. By pushing the boundaries of what's possible, 2seventy bio strives to develop groundbreaking treatments that address the limitations of existing therapies.

Examples of how 2seventy bio demonstrates this value include:

• Research and development: Investing significantly in cutting-edge research to discover new therapeutic approaches. For the year 2024, 2seventy bio reported research and development expenses of $223.1 million.
• Strategic partnerships: Collaborating with leading academic institutions and biotechnology companies to accelerate innovation.
• Technology platforms: Developing proprietary technology platforms that enable the efficient and precise engineering of cells.

Integrity

Integrity is fundamental to 2seventy bio's operations. The company is committed to conducting its business with the highest ethical standards, ensuring transparency, and maintaining accountability in all its interactions. By upholding integrity, 2seventy bio builds trust with patients, partners, and shareholders.

Examples of how 2seventy bio demonstrates this value include:

• Compliance: Adhering to all applicable laws, regulations, and industry codes of conduct.
• Ethical conduct: Promoting a culture of honesty, fairness, and respect in all business dealings.
• Transparency: Communicating openly and honestly with stakeholders about the company's activities and performance.

Teamwork

Teamwork is essential to 2seventy bio's success. The company fosters a collaborative environment where individuals with diverse skills and backgrounds work together to achieve common goals. By leveraging the collective expertise of its employees, 2seventy bio accelerates progress and delivers better outcomes.

Examples of how 2seventy bio demonstrates this value include:

• Cross-functional collaboration: Encouraging collaboration across different departments and teams.
• Knowledge sharing: Facilitating the sharing of information and best practices throughout the organization.
• Employee development: Investing in training and development programs to enhance employees' skills and capabilities.

Community

2seventy bio is committed to being a responsible corporate citizen and contributing to the well-being of the communities in which it operates. The company supports initiatives that promote education, health, and social welfare. By giving back to the community, 2seventy bio strives to make a positive impact on society.

Examples of how 2seventy bio demonstrates this value include:

• Philanthropy: Supporting charitable organizations that align with the company's mission and values.
• Volunteerism: Encouraging employees to volunteer their time and skills to support local communities.
• Sustainability: Implementing environmentally sustainable practices to minimize the company's impact on the planet.